Sharon Tamir

Sharon Tamir is a professional with extensive experience in digital healthcare innovation and strategic leadership within the pharmaceutical industry. Currently serving at Mitsubishi Tanabe Pharma America, Sharon leads the implementation of digital healthcare technologies in clinical projects. Previously, at Karyopharm Therapeutics Inc., Sharon held multiple senior roles, including Vice President and Head of Neuro-oncology & Myelofibrosis, focusing on the development of Selinexor for treating various cancers. Experience also includes positions at United Neuroscience, where responsibilities involved strategic alliances and overseeing research in neurodegenerative diseases, as well as a history in private practice as a naturopath. Sharon's educational background includes a Bachelor's degree in Psychology from The Open University of Israel and various certifications in complementary medicine and reflexology.